VCYT · XBRL financial data

Veracyte financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (VCYT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	117	220	297	361	446	517
Gross profit	—	—	176	230	298	363
Research and development	17	30	41	57	69	71
General and administrative	37	101	77	86	111	111
Operating income (loss)	(35)	(82)	(41)	(86)	16	58
Interest expense	0	—	—	—	—	—
Other income (expense)	1	0	5	9	10	10
Income tax expense (benefit)	0	(6)	0	(2)	2	2
Net income (loss)	(35)	(76)	(37)	(74)	24	66
Earnings per share, basic USD per share	(0.66)	(1.11)	(0.51)	(1.02)	0.32	0.84
Earnings per share, diluted USD per share	(0.66)	(1.11)	(0.51)	(1.02)	0.31	0.82
Weighted average shares, basic millions of shares	53	68	72	73	76	79
Weighted average shares, diluted millions of shares	53	68	72	73	78	81

Fiscal years (VCYT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	349	173	154	216	239	363
Short-term investments	—	—	—	—	—	50
Accounts receivable	18	41	44	40	47	45
Inventory	5	11	14	16	22	21
Prepaid and other current assets	3	17	11	13	15	10
Total current assets	376	243	249	286	372	488
Property and equipment, net	9	15	18	—	—	—
Right-of-use asset	8	16	13	10	48	37
Goodwill	3	708	696	703	746	767
Total assets	457	1,188	1,156	1,115	1,300	1,406
Accounts payable	3	12	12	13	9	5
Accrued liabilities	12	39	38	38	44	49
Current portion of long-term debt	0	1	0	—	—	—
Total current liabilities	17	64	63	61	79	60
Long-term debt	1	0	—	—	—	—
Lease liability, non-current	10	14	11	8	43	36
Total liabilities	36	91	81	71	124	96
Accumulated deficit	(282)	(357)	(394)	(468)	(444)	(378)
Total stockholders' equity	421	1,097	1,075	1,044	1,176	1,310
Total liabilities and equity	457	1,188	1,156	1,115	1,300	1,406
Common shares outstanding (cover page) millions of shares	67	71	72	75	78	79

Fiscal years (VCYT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(35)	(76)	(37)	(74)	24	66
Stock-based compensation	13	23	27	33	36	44
Depreciation and amortization	8	20	26	27	23	21
Net cash from operating activities	(10)	(32)	8	44	75	136
Purchases of property and equipment	3	5	9	10	11	10
Net cash from investing activities	(4)	(739)	(29)	15	(56)	(9)
Repayments of long-term debt	0	0	1	0	0	—
Net cash from financing activities	204	596	3	3	5	(4)
Net change in cash	190	(176)	(19)	62	23	124

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Veracyte	300	150	46*	80.4M	—	Q2 FY26 10-QJun 30, 2026
GRAIL	56	45	(81)*	44.7M	0.7 quarters	Q2 FY26 10-QJun 30, 2026
BillionToOne	562	123	not reported	not reported	—	Q3 FY26 10-QSep 30, 2026
CareDx	250	139	13*	52.5M	—	Q3 FY26 10-QSep 30, 2026
Lumexa Imaging Holdings	70	264	33*	96.1M	—	Q2 FY26 10-QJun 30, 2026
Caris Life Sciences	not reported	275	not reported	286.8M	—	Q3 FY26 10-QSep 30, 2026
RadNet	726	623	94*	78.7M	—	Q2 FY26 10-QJun 30, 2026
Personalis	98	26	(27)*	108.4M	6.7 quarters	Q3 FY26 10-QSep 30, 2026
Castle Biosciences	62	104	15*	30.5M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.